Cy5.5 NHS Ester (Non-Sulfonated): Transforming Near-Infrared Fluorescence Imaging and Biomolecule Labeling

Principle and Setup: Why Cy5.5 NHS Ester (Non-Sulfonated) Matters

Cy5.5 NHS ester (non-sulfonated) is a near-infrared fluorescent dye designed specifically for covalent labeling of primary amines on biomolecules—proteins, peptides, or oligonucleotides. With an excitation maximum at ~684 nm and emission around 710 nm, its spectral profile achieves deep tissue penetration and low background autofluorescence, key for in vivo fluorescence imaging and sensitive detection in complex biological samples. The dye's robust NHS ester chemistry forms stable amide bonds, ensuring long-term signal retention and reproducibility in labeling workflows.

This reagent is supplied as a solid and is highly soluble in organic solvents like DMSO (≥35.82 mg/mL), but poorly soluble in water. As such, it requires a workflow that introduces it in an organic co-solvent before reacting with biomolecules in aqueous buffer—a crucial detail for labeling efficiency and downstream assay performance, as detailed in the product information.

Step-by-Step Workflow: From Dissolution to Conjugation

Efficient use of Cy5.5 NHS ester (non-sulfonated) starts with mastering its dissolution and conjugation protocol. Below, we break down the process, integrating best practices and highlighting crucial steps for reproducible, high-performance labeling.

Protocol Parameters

• Dye dissolution: Dissolve Cy5.5 NHS ester (non-sulfonated) at 10 mM in anhydrous DMSO; vortex thoroughly, protect from light, and use within 30 minutes for maximal reactivity.
• Protein labeling reaction: Add the DMSO-dye solution to your protein (1–5 mg/mL in 0.1 M sodium bicarbonate buffer, pH 8.3), maintaining a molar dye-to-protein ratio between 3:1 and 10:1; incubate at room temperature for 1 hour, shielded from light.
• Purification: Remove excess dye by gel filtration (Sephadex G-25) or repeated centrifugal filtration (10 kDa cutoff), equilibrated in PBS or your desired buffer; collect labeled biomolecule, quantify using A280/A684 ratio, and proceed immediately to downstream applications.

These parameters are grounded in standard protocols and have been validated for optimal labeling efficiency and preservation of biomolecule bioactivity, as also discussed in comparative workflow guides for fluorescent dye for protein conjugation.

Key Innovation from the Reference Study

The recent study on Oudemansiella raphanipies polysaccharides exemplifies the power of advanced extraction and imaging integration. By optimizing ultrasonic-assisted extraction (UAE) for high-yield, bioactive polysaccharides and using near-infrared (NIR) imaging to track their in vivo distribution, the authors demonstrate how pairing robust extraction with sensitive detection enables quantitative, real-time monitoring of bioactive compounds in living systems.

For researchers labeling similar biopolymers or proteins, adopting a workflow with Cy5.5 NHS ester (non-sulfonated) can translate this innovation into practice: its NIR fluorescence enables precise tracking of labeled biomolecules through gastrointestinal or systemic routes, mirroring the reference study's success in visualizing polysaccharide retention and distribution. This workflow supports both pharmacokinetic studies and prebiotic/therapeutic agent development.

Advanced Applications and Comparative Advantages

Cy5.5 NHS ester (non-sulfonated) is widely adopted for:

• Optical imaging of tumors: Its deep tissue penetration and low background make it ideal for delineating tumor margins and tracking labeled antibodies or peptides in animal models, as reported in the tumor visualization workflow.
• In vivo fluorescence imaging: The dye's high extinction coefficient (209,000 M⁻¹cm⁻¹) and quantum yield (0.2) yield strong, stable signals for live-animal imaging and biodistribution studies, with performance benchmarks detailed in the precision labeling review.
• Labeling of high-molecular-weight biopolymers: As shown in the reference study, effective tracking of macromolecules like polysaccharides hinges on efficient labeling and detection, areas where Cy5.5 NHS ester excels.
• Multiplexed imaging: Its NIR emission allows for channel separation from other fluorophores (e.g., FITC, Cy3), supporting multi-target studies in both cells and tissues.

Compared to sulfonated dyes, the non-sulfonated variant offers enhanced membrane permeability, expanding its utility for labeling both extracellular and intracellular targets. This flexibility is crucial for translational research, where experimental design frequently crosses from cell cultures to whole-animal imaging.

Troubleshooting and Optimization Tips

• Low labeling efficiency? Confirm dye is fully dissolved in dry DMSO, and ensure the biomolecule buffer is amine-free and at optimal pH (8.3). Avoid Tris buffers, which compete for NHS esters.
• High background or aggregation? Excess dye or suboptimal purification can cause background fluorescence or protein aggregation. Use size-exclusion chromatography and optimize the dye:protein ratio for your target.
• Loss of fluorescence after storage? Cy5.5 NHS ester-labeled biomolecules should be aliquoted and stored at -20°C in the dark. Use freshly prepared dye solutions, as they degrade rapidly, as noted in the product specifications.
• Batch-to-batch variability? Standardize your labeling reactions using a fixed molar ratio and quantify labeling efficiency via absorbance at 684 nm post-purification. Inter-lab reproducibility improves with consistent dye quality; sourcing from APExBIO ensures batch reliability.

For additional scenario-based troubleshooting, the cell assay optimization guide provides practical Q&A addressing common workflow pain points, from cytotoxicity assessment to multiplex labeling challenges.

Why This Cross-Domain Matters, Maturity, and Limitations

The integration of advanced extraction (UAE) and near-infrared fluorescence imaging, as demonstrated in the reference study, bridges food chemistry, pharmacology, and molecular imaging. By enabling real-time visualization of bioactive polysaccharides in vivo, this approach accelerates both functional food additive development and therapeutic agent characterization. However, translation from animal models to human studies remains a challenge due to differences in tissue optical properties and metabolic processing. The maturity of Cy5.5 NHS ester (non-sulfonated) as a fluorescent dye for protein conjugation is well-established in preclinical research, but clinical adoption will require further validation of safety and stability in human systems.

Future Outlook: Expanding Utility in Translational Research

As demands for sensitive, multiplexed, and quantitative imaging grow, Cy5.5 NHS ester (non-sulfonated) is well-positioned to enable next-generation studies—whether tracking novel biopolymers, visualizing tumor microenvironments, or optimizing drug delivery systems. Ongoing advances in extraction, purification, and imaging technologies will further enhance the impact of NIR dyes in both academic and applied settings.

For researchers requiring reproducible, high-sensitivity labeling, APExBIO’s Cy5.5 NHS ester (non-sulfonated) remains a trusted solution, delivering robust performance across diverse experimental workflows.